---
figid: PMC2674743__JLR50SUPPS74f2
figlink: /pmc/articles/PMC2674743/figure/fig2/
number: Fig. 2
caption: Altered insulin signaling by lipid intermediates. Increased nutrient influx
  raises intracellular FA concentrations. With nutrient surfeit, elevated malonyl-CoA
  inhibits CPT-1 and β-oxidation and results in increased availability of acyl-CoAs
  for TAG synthesis and storage or secretion. Intermediates in the TAG biosynthetic
  pathway activate inhibitors of insulin signaling, including protein kinase C (PKC),
  mTOR, and S6K, which suppress IRS-1 activation of PIP3. Ceramide inhibits Akt-mediated
  insulin signaling, derepressing FOXO and leading to increases in transcription of
  phosphoenolpyruvate (PEPCK) and glucose-6-phosphatase (G-6-Pase). These enhance
  gluconeogenesis and hepatic glucose output. Nutrients act on transcription factors
  (LXR, ChREBP, SREBP-1c and PPAR γ), which increase transcription of genes involved
  in FA and TAG synthesis (ACC, FAS, GPAT1). These enhance steatosis and hepatic insulin
  resistance. DHAP, dihydroxyacetone-P; G3P, glycerol-3-P; GSK, glycogen synthase
  kinase.
pmcid: PMC2674743
papertitle: Hepatic triacylglycerol accumulation and insulin resistance.
reftext: Cynthia A. Nagle, et al. J Lipid Res. 2009 Apr;50(Suppl):S74-S79.
pmc_ranked_result_index: '5147'
pathway_score: 0.9667936
filename: JLR50SUPPS74f2.jpg
figtitle: Altered insulin signaling by lipid intermediates
year: '2009'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2674743__JLR50SUPPS74f2.html
  '@type': Dataset
  description: Altered insulin signaling by lipid intermediates. Increased nutrient
    influx raises intracellular FA concentrations. With nutrient surfeit, elevated
    malonyl-CoA inhibits CPT-1 and β-oxidation and results in increased availability
    of acyl-CoAs for TAG synthesis and storage or secretion. Intermediates in the
    TAG biosynthetic pathway activate inhibitors of insulin signaling, including protein
    kinase C (PKC), mTOR, and S6K, which suppress IRS-1 activation of PIP3. Ceramide
    inhibits Akt-mediated insulin signaling, derepressing FOXO and leading to increases
    in transcription of phosphoenolpyruvate (PEPCK) and glucose-6-phosphatase (G-6-Pase).
    These enhance gluconeogenesis and hepatic glucose output. Nutrients act on transcription
    factors (LXR, ChREBP, SREBP-1c and PPAR γ), which increase transcription of genes
    involved in FA and TAG synthesis (ACC, FAS, GPAT1). These enhance steatosis and
    hepatic insulin resistance. DHAP, dihydroxyacetone-P; G3P, glycerol-3-P; GSK,
    glycogen synthase kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACACA
  - AKT3
  - MLXIPL
  - PRKD3
  - SREBF1
  - PRKCA
  - SLC2A2
  - PRKCE
  - PRKCH
  - AGPAT1
  - FAS
  - AKT2
  - PCK2
  - PRKCB
  - AKT1
  - FOXO6
  - FOXO1
  - PRKCZ
  - GSK3A
  - ACACB
  - MTOR
  - PRKCQ
  - GSK3B
  - FOXO4
  - PRKCD
  - FOXO3
  - PRKCG
  - PRKCI
  - acyl-CoA
  - ceramide
  - glucose
  - glucose-6-P
  - pyruvate
  - serine
  - Cancer
genes:
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CHREBP
  symbol: CHREBP
  source: hgnc_alias_symbol
  hgnc_symbol: MLXIPL
  entrez: '51085'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: SREBP-1c+
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: GLUT2
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: aGPAT1
  symbol: AGPAT1
  source: hgnc_symbol
  hgnc_symbol: AGPAT1
  entrez: '10554'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: „PEPCK
  symbol: PEPCK
  source: hgnc_alias_symbol
  hgnc_symbol: PCK2
  entrez: '5106'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
chemicals:
- word: acyl-CoA
  source: MESH
  identifier: D000214
- word: ceramide
  source: MESH
  identifier: D002518
- word: glucose
  source: MESH
  identifier: D005947
- word: glucose-6-P
  source: MESH
  identifier: D005947
- word: pyruvate
  source: MESH
  identifier: D011773
- word: serine
  source: MESH
  identifier: D012694
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
